Clinical Trials Browser

Phase 2/3 × Carcinoma, Non-Small-Cell Lung × pazopanib × Clear all

NCT00775307 2019-09-24

Adjuvant Pazopanib in Stage I NSCLC

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung